Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 486

1.

Thyroid carcinoma: epidemiology, histology, and diagnosis.

Shah JP.

Clin Adv Hematol Oncol. 2015 Apr;13(4 Suppl 4):3-6. No abstract available.

PMID:
25856096
2.

Detailed Analysis of Clinicopathologic Factors Demonstrate Distinct Difference in Outcome and Prognostic Factors Between Surgically Treated HPV-Positive and Negative Oropharyngeal Cancer.

Iyer NG, Dogan S, Palmer F, Rahmati R, Nixon IJ, Lee N, Patel SG, Shah JP, Ganly I.

Ann Surg Oncol. 2015 Mar 24. [Epub ahead of print]

PMID:
25801358
3.

A phase II trial of bevacizumab + cetuximab + cisplatin with concurrent intensity modulated radiation therapy (IMRT) for patients with stage III/IVB head and neck squamous cell carcinoma (HNSCC).

Fury MG, Xiao H, Sherman EJ, Baxi S, Smith-Marrone S, Schupak K, Gewanter R, Gelblum D, Haque S, Schoder H, Shah JP, Katabi N, Kurtzman R, Lipson B, Cox L, Lee NY, Pfister DG.

Head Neck. 2015 Mar 17. doi: 10.1002/hed.24041. [Epub ahead of print]

PMID:
25784616
4.

Role of surgical therapy for thyroid cancer.

Shah JP.

Clin Adv Hematol Oncol. 2014 Jul;12(7 Suppl 14):6-9. No abstract available.

PMID:
25768716
5.

Prognostic Value of Vascular Invasion in Well-Differentiated Papillary Thyroid Carcinoma.

Wreesmann VB, Nixon IJ, Rivera M, Katabi N, Palmer F, Ganly I, Shaha AR, Tuttle RM, Shah JP, Patel SG, Ghossein RA.

Thyroid. 2015 Mar 31. [Epub ahead of print]

PMID:
25748079
6.

Distant Metastases in Patients with Carcinoma of the Major Salivary Glands.

Ali S, Bryant R, Palmer FL, DiLorenzo M, Shah JP, Patel SG, Ganly I.

Ann Surg Oncol. 2015 Mar 6. [Epub ahead of print]

PMID:
25743328
7.

Myofascial Trigger Points Then and Now: A Historical and Scientific Perspective.

Shah JP, Thaker N, Heimur J, Aredo JV, Sikdar S, Gerber L.

PM R. 2015 Feb 24. pii: S1934-1482(15)00079-9. doi: 10.1016/j.pmrj.2015.01.024. [Epub ahead of print] Review.

PMID:
25724849
8.

Soft tissue sarcoma of the head & neck: Nomogram validation and analysis of staging systems.

Shuman AG, Brennan MF, Palmer FL, Kuk D, Moraco N, Singer S, Shah JP, Patel SG.

J Surg Oncol. 2015 Feb 24. doi: 10.1002/jso.23868. [Epub ahead of print]

PMID:
25711850
9.

Lateral Neck Lymph Node Characteristics Prognostic of Outcome in Patients with Clinically Evident N1b Papillary Thyroid Cancer.

Wang LY, Palmer FL, Nixon IJ, Tuttle RM, Shah JP, Patel SG, Shaha AR, Ganly I.

Ann Surg Oncol. 2015 Feb 10. [Epub ahead of print]

PMID:
25665952
10.

Guideline familiarity predicts variation in self-reported use of routine surveillance PET/CT by physicians who treat head and neck cancer.

Roman BR, Patel SG, Wang MB, Pou AM, Holsinger FC, Myssiorek D, Goldenberg D, Swisher-McClure S, Lin A, Shah JP, Shea JA.

J Natl Compr Canc Netw. 2015 Jan;13(1):69-77.

PMID:
25583771
11.

Brønsted acid catalyzed monoalkylation of anilines with trichloroacetimidates.

Wallach DR, Stege PC, Shah JP, Chisholm JD.

J Org Chem. 2015 Feb 6;80(3):1993-2000. doi: 10.1021/jo5027222. Epub 2015 Jan 16.

PMID:
25568933
12.

Thyroid carcinoma, version 2.2014.

Tuttle RM, Haddad RI, Ball DW, Byrd D, Dickson P, Duh QY, Ehya H, Haymart M, Hoh C, Hunt JP, Iagaru A, Kandeel F, Kopp P, Lamonica DM, Lydiatt WM, McCaffrey J, Moley JF, Parks L, Raeburn CD, Ridge JA, Ringel MD, Scheri RP, Shah JP, Sherman SI, Sturgeon C, Waguespack SG, Wang TN, Wirth LJ, Hoffmann KG, Hughes M.

J Natl Compr Canc Netw. 2014 Dec;12(12):1671-80; quiz 1680.

PMID:
25505208
13.

Comparable outcomes for patients with pT1a and pT1b differentiated thyroid cancer: Is there a need for change in the AJCC classification system?

Wang LY, Nixon IJ, Palmer FL, Thomas D, Tuttle RM, Shaha AR, Patel SG, Shah JP, Ganly I.

Surgery. 2014 Dec;156(6):1484-9; discussion 1489-90. doi: 10.1016/j.surg.2014.08.037. Epub 2014 Nov 11.

PMID:
25456937
14.

Current treatment of T1N0 squamous cell carcinoma of the glottic larynx.

Mendenhall WM, Takes RP, Shah JP, Bradley PJ, Beitler JJ, Strojan P, Suárez C, Rodrigo JP, Saba NF, Rinaldo A, Werner JA, Ferlito A.

Eur Arch Otorhinolaryngol. 2014 Nov 8. [Epub ahead of print] No abstract available.

PMID:
25381098
15.

Head and neck cancers, Version 2.2014. Clinical practice guidelines in oncology.

Pfister DG, Spencer S, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL Jr, Hitchcock YJ, Jimeno A, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rodriguez CP, Samant S, Schuller DE, Shah JP, Weber RS, Wolf GT, Worden F, Yom SS, McMillian NR, Hughes M.

J Natl Compr Canc Netw. 2014 Oct;12(10):1454-87.

PMID:
25313184
16.

Central lymph node characteristics predictive of outcome in patients with differentiated thyroid cancer.

Wang LY, Palmer FL, Nixon IJ, Thomas D, Shah JP, Patel SG, Tuttle RM, Shaha AR, Ganly I.

Thyroid. 2014 Dec;24(12):1790-5. doi: 10.1089/thy.2014.0256.

PMID:
25268855
17.

A Comparison of the American Joint Committee on Cancer N1 versus N2a nodal categories for predicting survival and recurrence in patients with oral cancer: Time to acknowledge an arbitrary distinction and modify the system.

Ebrahimi A, Gil Z, Amit M, Yen TC, Liao CT, Chaturvedi P, Agarwal JP, Kowalski LP, Kreppel M, Cernea CR, Brandao SJ, Bachar G, Bolzoni Villaret A, Fliss D, Fridman E, Robbins KT, Shah JP, Patel SG, Clark JR; The International Consortium for Outcome Research (ICOR) in Head and Neck Cancer.

Head Neck. 2014 Sep 16. doi: 10.1002/hed.23871. [Epub ahead of print]

PMID:
25227311
18.

Level 7 disease does not confer worse outcome than level 6 disease in differentiated thyroid cancer.

Wang LY, Palmer FL, Thomas D, Nixon IJ, Tuttle RM, Shah JP, Patel SG, Shaha AR, Ganly I.

Ann Surg Oncol. 2015 Feb;22(2):441-5. doi: 10.1245/s10434-014-4045-3. Epub 2014 Sep 5.

PMID:
25190124
19.

Multi-organ distant metastases confer worse disease-specific survival in differentiated thyroid cancer.

Wang LY, Palmer FL, Nixon IJ, Thomas D, Patel SG, Shaha AR, Shah JP, Tuttle RM, Ganly I.

Thyroid. 2014 Nov;24(11):1594-9. doi: 10.1089/thy.2014.0173. Epub 2014 Sep 24.

PMID:
25162180
20.

Primary tumor staging for oral cancer and a proposed modification incorporating depth of invasion: an international multicenter retrospective study.

International Consortium for Outcome Research (ICOR) in Head and Neck Cancer, Ebrahimi A, Gil Z, Amit M, Yen TC, Liao CT, Chaturvedi P, Agarwal JP, Kowalski LP, Kreppel M, Cernea CR, Brandao J, Bachar G, Bolzoni Villaret A, Fliss D, Fridman E, Robbins KT, Shah JP, Patel SG, Clark JR.

JAMA Otolaryngol Head Neck Surg. 2014 Dec;140(12):1138-48. doi: 10.1001/jamaoto.2014.1548.

PMID:
25075712
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk